Palatin Technologies Company
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
.jpg)
Total Funding:
$104 000 000
Headquarters:
Cranbury, New Jersey, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Technology:
Cancer
Last Funding Date:
2016-12-08
Founded Date:
1986
Industry:
Sexual Healthcare